J Korean Ophthalmol Soc.  2013 Apr;54(4):568-573. 10.3341/jkos.2013.54.4.568.

Comparison of Herpes Zoster Ophthalmicus in Patients 60 Years Older Versus Younger than 60 Years

  • 1Department of Ophthalmology, Chonbuk National University Medical School, Jeonju, Korea. you2ic@paran.com


To analyze and compare the clinical characteristics of patients with herpes zoster ophthalmicus (HZO) by age groups on the basis of the age of 60.
Medical records of patients with HZO who visited Chonbuk National University Hospital from February 1, 2002 to February 28, 2011 were reviewed. The patients with follow-up of three months or more were divided into two groups: patients under 60 and patients with 60 years old and over. The clinical characteristics between two groups were examined through the analysis of their medical records.
Among a total of 63 patients, 29 patients (46%) were under 60 years old, and 34 patients (54%) were 60 years old and over. Incidence of HZO highest in the sixties. The sex and intrusion of each group showed no difference. Younger patients had a higher incidence of pseudodendrite by HZO (86.2% vs. 58.8%, p = 0.014) compared with older patients who showed a higher incidence of post herpetic neuralgia (13.8% vs. 35.3%, p = 0.046). As patients showed Hutchinson's sign, they often had more ocular complications such as pseudodendrite (100% vs. 64.7%, p < 0.05), uveitis (41.7% vs. 7.8%, p = 0.04), and conjunctivitis (100% vs. 90.2%, p = 0.02).
Herpes zoster ophthalmicus shows different clinical characteristics according to patients' age and requires appropriate treatment. Especially elderly patients showing Hutchinson's sign should be treated early and aggressively enough.


Age; Herpes zoster ophthalmicus; Hutchinson's sign; Postherpetic neuralgia; Pseudodendrite

MeSH Terms

Follow-Up Studies
Herpes Zoster
Herpes Zoster Ophthalmicus
Medical Records
Neuralgia, Postherpetic


  • Figure 1. Distribution of age at time of diagnosis of herpes zoster ophthalmicus by decade.

Cited by  1 articles

A Case of Multiple Complications in Herpes Zoster Ophthalmicus
Yeong Woo Son, Jin Hyun Kim, Seung Woo Lee
J Korean Ophthalmol Soc. 2015;56(5):789-793.    doi: 10.3341/jkos.2015.56.5.789.



1. Ostler HB, Thygeson P. The ocular manifestations of herpes zoster, varicella, infectious mononucleosis, and cytomegalovirus disease. Surv Ophthalmol. 1976; 21:148–59.
2. Ragozzino MW, Melton LJ 3rd, Kurland LT, et al. Population based study of herpes zoster and its sequelae. Medicine (Baltimore). 1982; 61:310–6.
3. Arvin AM. Varicella-zoster virus. Clin Microbiol Rev. 1996; 9:361–81.
4. Arvin A. Aging, immunity, and the varicella-zoster virus. N Engl J Med. 2005; 352:2266–7.
5. Oxman MN. Immunization to reduce the frequency and severity of herpes zoster and its complications. Neurology. 1995; 45:S41–6.
6. Burke BL, Steele RW, Beard OW, et al. Immune responses to varicella-zoster in the aged. Arch Intern Med. 1982; 142:291–3.
7. Cohen PR, Grossman ME. Clinical features of HIV-associated disseminated herpes zoster virus infection: a review of literature. Clin Exp Dermatol. 1989; 14:273–6.
8. Buchbinder SP, Katz MH, Hessol NA, et al. Herpes zoster and human immunodeficiency virus infection. J Infect Dis. 1992; 166:1153–6.
9. Brisson M, Edmunds WJ, Law B, et al. Epidemiology of varicella zoster virus infection in Canada and the United kingdom. Epidemiol Infect. 2001; 127:305–14.
10. Lee HR, Cho BC. A clinical study of herpes zoster ophthalmicus. J Korean Ophthalmol Soc. 1988; 29:387–91.
11. Herpes zoster keratitis, Krachmer JH, Mannis MJ, Holland EJ. Cornea. 2nd ed.Philadelphia: Elsevier Mosby;2005. v. 1. chap. 84.
12. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005; 352:2271–84.
13. Nagasako EM, Johnson RW, Griffin DR, Dworkin RH. Rash severity in herpes zoster: correlates and relationship to postherpetic neuralgia. J Am Acad Dermatol. 2002; 46:834–9.
14. Liesegang TJ. Herpes zoster ophthalmicus: natural history, risk factors, clinical presentation, and morbidity. Ophthalmology. 2008; 115:S3–12.
15. Lee HJ, Kim SY, Jung MS. The clinical characteristics of facial herpes zoster in Korean patients. J Korean Ophthalmol Soc. 2010; 51:8–13.
16. Chung YR, Chang YH, Kim DH, Yang HS. Ocular manifestations of herpes zoster ophthalmicus. J Korean Ophthalmol Soc. 2010; 51:164–8.
17. Ghaznawi N, Virdi A, Dayan A, et al. Herpes zoster ophthalmicus: comparison of disease in patients 60 years and older versus younger than 60 years. Ophthalmology. 2011; 118:2242–50.
18. Zaal MJ, Völker-Dieben HJ, D'Amaro J. Prognostic value of Hutchinson's sign in acute herpes zoster ophthalmicus. Graefes Arch Clin Exp Ophthalmol. 2003; 241:187–91.
19. Gnann JW Jr., Whitley RJ. Clinical practice. Herpes zoster. N Engl J Med. 2002; 347:340–6.
20. Dworkin RH, Portenoy RK. Pain and its persistence in herpes zoster. Pain. 1996; 67:241–51.
21. De Morgas JM, Kierland RR. The outcome of patients with herpes zoster. AMA Arch Derm. 1957; 75:193–6.
22. Kost RG, Straus SE. Postherpetic neuralgia--pathogenesis, treatment, and prevention. N Engl J Med. 1996; 335:32–42.
23. Hope-Simpson RE. Postherpetic neuralgia. J R Coll Gen Pract. 1975; 25:571–5.
24. Hess TM, Lutz LJ, Nauss LA, Lamer TJ. Treatment of acute herpetic neuralgia. A case report and review of the literature. Minn Med. 1990; 73:37–40.
25. Dworkin RH, Schmader KE. Treatment and prevention of post-herpetic neuralgia. Clin Infect Dis. 2003; 36:877–82.
26. Hampton T. When shingles wanes but pain does not: researchers target chronic postherpetic neuralgia. JAMA. 2005; 293:2459–60.
27. Ragozzino MW, Melton LJ 3rd, Kurland LT, et al. Risk of cancer after herpes zoster: a population-based study. N Engl J Med. 1982; 307:393–7.
28. Donahue JG, Choo PW, Manson JE, Platt R. The incidence of herpes zoster. Arch Intern Med. 1995; 155:1605–9.
29. Harpaz R, Ortega-Sanchez IR, Seward JF. Advisory Committee of Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC), Prevention of herpes zoster: recommendations of the Advisory Committee of Immunization Practices (ACIP). MMWR Recomm Rep. 2008; 57:1–30.
30. Kaufman SC. Anterior segment complications of herpes zoster ophthalmicus. Ophthalmology. 2008; 115:S24–32.
31. Kang JH, Kim HB, Sohn JW, et al. Adult immunization schedule recommended by the korean society of infectious diseases, 2007. Infect Chemother. 2008; 40:1–13.
Full Text Links
  • JKOS
export Copy
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr